학술논문
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression†
Document Type
Academic Journal
Author
Source
Annals of Oncology. Nov 01, 2017 28(11):2899-2899
Subject
Language
English
ISSN
0923-7534